Sustaining the momentum for provider status for pharmacists was a major focus of a Chain Drug Review roundtable at the NACDS Total Store Expo. Panelists also discussed the industry’s battle with pharmacy benefit managers and the investigation of PBMs by the Federal Trade Commission, as well as friction between pharmacy and the AMA. WOLDT: Brian,
The pandemic has brought — in addition to peril — promise for pharmacy operators who have become central to testing and vaccination efforts. The impact of the crisis on pharmacy’s present and future, among other topics, was explored during a Chain Drug Review roundtable held virtually in conjunction with the NACDS Total Store Expo. Woldt:
Key leaders in community pharmacy recently assembled for a roundtable sponsored by Chain Drug Review to discuss the profession’s impact on health care during the COVID-19 outbreak and beyond. In these highlights from the meeting, panelists from the retailing, pharmaceutical manufacturing and technology sides of the business address the industry’s response to the pandemic, the
